Search

Andreas Reichelt

from Moorpark, CA
Age ~51
Get Report
Also known as:
Andrea Reichelt
Phone and address:
6625 Pinnacle Way, Moorpark, CA 93021
(805) 906-0013
Related to:
George D Roane, 71John Anthony King, 64Wonsook K Kim, 78
Connected to:
Adele Reichel, 43Albert F Reichenbach, 72Alison V Reichenthal, 42Allison M Reichenberg, 30Amanda Reichenberger, 30Amanda S Reichenbach, 40Angela H Reichel, 112Anna R Reichenbach, 99Asha L Reichel, 38Brittney D Reichelt, 34

Andreas Reichelt Phones & Addresses

  • 6625 Pinnacle Way, Moorpark, CA 93021 (805) 906-0013
  • 11 Marion Rd, Belmont, MA 02478
  • Thousand Oaks, CA
  • 2822 Rio Grande St, Austin, TX 78705
  • Ventura, CA
  • 6625 Pinnacle Way, Moorpark, CA 93021

Publications

Isbn (Books And Publications)

Verfahren, Zulassigkeit Und Auswirkungen Der DNA-Technologie (Genetischer Fingerabdruck) Auf Den Anwendungsbereich Der Vaterschaftsvermutung Im Rahmen Des Paragraphen 1600 O II BGB

View page
Author

Andreas Reichelt

ISBN #

3769402367

Us Patents

Heterocyclic Modulators Of Pkb

View page
US Patent:
7897619, Mar 1, 2011
Filed:
Jul 16, 2008
Appl. No.:
12/218754
Inventors:
Qingping Zeng - Thousand Oaks CA, US
Dawei Zhang - Thousand Oaks CA, US
Guomin Yao - Newbury Park CA, US
George E. Wohlhieter - Lake Balboa CA, US
Xianghong Wang - Moorpark CA, US
James Rider - Woodland Hills CA, US
Andreas Reichelt - Moorpark CA, US
Holger Monenschein - Camarillo CA, US
James R. Falsey - Moorpark CA, US
Celia Dominguez - Los Angeles CA, US
Matthew P. Bourbeau - Woodland Hills CA, US
John G. Allen - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/47
A61K 31/416
C07D 217/02
C07D 231/56
US Classification:
514311, 544224, 544235, 544242, 544253, 544283, 546112, 546139, 546152, 546157, 5483601, 5483611, 5483027, 5483064, 514248, 514299, 514387, 514403
Abstract:
The invention relates to heterocyclic compounds of Formula I and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein. The invention also relates to the therapeutic use of such compounds and compositions thereof in treating disease states associated with abnormal cell growth, cancer, inflammation, and metabolic disorders.

Substituted Pyrazolo[3,4-D]Pyrimidines As Pi3K Inhibitors

View page
US Patent:
7919498, Apr 5, 2011
Filed:
Mar 24, 2008
Appl. No.:
12/079281
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Garwood NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 487/04
A61K 31/519
A61P 19/02
A61P 29/00
US Classification:
5142621, 544262, 544280, 5142651
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukemia (AML) Myelodysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Thiadiazole Modulators Of Pkb

View page
US Patent:
7919504, Apr 5, 2011
Filed:
Jul 15, 2008
Appl. No.:
12/218523
Inventors:
Qingping Zeng - Thousand Oaks CA, US
Chester Chenguang Yuan - Newbury Park CA, US
Guomin Yao - Newbury Park CA, US
Xianghong Wang - Moorpark CA, US
Seifu Tadesse - Simi Valley CA, US
Andreas Reichelt - Moorpark CA, US
Qingyian Liu - Camarillo CA, US
Matthew R. Lee - Calabasas CA, US
Xin Huang - Roslindale MA, US
Nianhe Han - Thousand Oaks CA, US
Christopher H. Fotsch - Thousand Oaks CA, US
Celia Dominguez - Los Angeles CA, US
Matthew P. Bourbeau - Woodland Hills CA, US
John G. Allen - Newbury Park CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/47
C07D 401/04
US Classification:
514307, 546144
Abstract:
The invention relates to thiazole compounds of Formula I and Formula II and compositions thereof useful for treating diseases mediated by protein kinase B (PKB) where the variables have the definitions provided herein.

Heterocyclic Compounds And Their Uses

View page
US Patent:
8183258, May 22, 2012
Filed:
Jul 20, 2011
Appl. No.:
13/187135
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/47
US Classification:
514314
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Heterocyclic Compounds And Their Uses

View page
US Patent:
8183259, May 22, 2012
Filed:
Jul 20, 2011
Appl. No.:
13/187154
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/47
US Classification:
514314
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity, The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including but not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.

Heterocyclic Compounds And Their Uses

View page
US Patent:
8193199, Jun 5, 2012
Filed:
Mar 24, 2008
Appl. No.:
12/079406
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Jason A. Duquette - Millbrae CA, US
Felix Gonzalez Lopez De Turiso - San Mateo CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Brian Lucas - San Francisco CA, US
Lawrence R. McGee - Pacifica CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Garwood NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 473/34
A61K 31/52
A61P 35/00
A61P 19/02
A61P 37/06
A61P 19/08
C07D 487/04
C07D 241/40
C07D 241/44
C07D 215/14
C07D 215/26
C07D 215/22
C07D 417/14
C07D 417/04
US Classification:
5142632, 51426322, 544265, 544277, 544278, 544280, 544353, 544354, 544356, 544119, 546119, 546167, 546168, 546173, 546175, 546180
Abstract:
Substituted bicyclic heteroaryls having the structures:.

Pyridine And Pyrimidine Derivatives As Phosphodiesterase 10 Inhibitors

View page
US Patent:
8318718, Nov 27, 2012
Filed:
Nov 16, 2009
Appl. No.:
12/619573
Inventors:
Jennifer R. Allen - Newbury Park CA, US
Biswas Kaustav - Agoura Hills CA, US
Frank Chavez - Camarillo CA, US
Ning Chen - Thousand Oaks CA, US
Frenel Fils De Morin - Thousand Oaks CA, US
James R. Falsey - Moorpark CA, US
Michael J. Frohn - Thousand Oaks CA, US
Paul E. Harrington - Camarillo CA, US
Daniel B. Horne - Simi Valley CA, US
Essa Hu Harrington - Camarillo CA, US
Matthew R. Kaller - Ventura CA, US
Roxanne Kunz - Santa Monica CA, US
Holger Monenschein - Jupiter FL, US
Thomas T. Nguyen - Newbury Park CA, US
Alexander J. Pickrell - Westlake Village CA, US
Andreas Reichelt - Moorpark CA, US
Shannon Rumfelt - Camarillo CA, US
Robert M. Rzasa - Ventura CA, US
Kelvin Sham - Thousand Oaks CA, US
Guomin Yao - Camarillo CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
A61K 31/4439
A61K 31/437
A61K 31/52
A61K 31/5377
A61K 31/55
A61K 31/397
C07D 401/12
C07D 471/04
C07D 473/00
C07D 413/14
C07D 401/14
A61P 25/00
US Classification:
51421021, 514303, 514338, 51426322, 5142358, 51421208, 5462734, 546118, 544277, 544131
Abstract:
Pyridine and pyrimidine compounds, and compositions containing them, and processes for preparing such compounds. Provided herein also are methods of treating disorders or diseases treatable by inhibition of PDE10, such as obesity, non-insulin dependent diabetes, schizophrenia, bipolar disorder, obsessive-compulsive disorder, and the like.

Quinolines For The Treatment Of Pi3K-Δ Mediated Diseases

View page
US Patent:
8329910, Dec 11, 2012
Filed:
Jul 20, 2011
Appl. No.:
13/187188
Inventors:
Yi Chen - San Mateo CA, US
Timothy D. Cushing - Pacifica CA, US
Xiaolin Hao - Foster City CA, US
Xiao He - Foster City CA, US
Andreas Reichelt - Moorpark CA, US
Robert M. Rzasa - Ventura CA, US
Jennifer Seganish - Scotch Plains NJ, US
Youngsook Shin - Emeryville CA, US
Dawei Zhang - Thousand Oaks CA, US
Assignee:
Amgen Inc. - Thousand Oaks CA
International Classification:
C07D 215/12
US Classification:
546176
Abstract:
Substituted bicyclic heteroaryls and compositions containing them, for the treatment of general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, including but not restricted to autoimmune diseases such as systemic lupus erythematosis (SLE), myestenia gravis, rheumatoid arthritis, acute disseminated encephalomyelitis, idiopathic thrombocytopenic purpura, multiples sclerosis, Sjoegren's syndrome and autoimmune hemolytic anemia, allergic conditions including all forms of hypersensitivity. The present invention also enables methods for treating cancers that are mediated, dependent on or associated with p110δ activity, including nut not restricted to leukemias, such as Acute Myeloid leukaemia (AML) Myelo-dysplastic syndrome (MDS) myelo-proliferative diseases (MPD) Chronic Myeloid Leukemia (CML) T-cell Acute Lymphoblastic leukaemia (T-ALL) B-cell Acute Lymphoblastic leukaemia (B-ALL) Non Hodgkins Lymphoma (NHL) B-cell lymphoma and solid tumors, such as breast cancer.
Control profile
Andreas Reichelt from Moorpark, CA, age ~51 Get Report